Regulation of MUC5B expression in idiopathic pulmonary fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 57, Issue 1, 2017, Pages 91-99

  Helling, Britney A ^a   Gerber, Anthony N ^a,b   Kadiyala, Vineela ^b   Sasse, Sarah K ^b   Pedersen, Brent S ^a   Sparks, Lenore ^a   Nakano, Yasushi ^a   Okamoto, Tsukasa ^a   Evans, Christopher M ^a   Yang, Ivana V ^a,c   Schwartz, David A ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

DNA methylation; Gene regulation; Idiopathic pulmonary fibrosis; Mucin 5B; Mucins

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; DNA; E1A ASSOCIATED P300 PROTEIN; ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE DEACETYLASE 2; MONOCLONAL ANTIBODY E74; MUCIN 5B; NUCLEAR FACTOR I; PAIRED BOX TRANSCRIPTION FACTOR; RETINOID X RECEPTOR ALPHA; RNA; RNA POLYMERASE II; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR TEAD4; TRANSCRIPTION FACTOR ZBTB; UNCLASSIFIED DRUG; FOXA2 PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; FIBROSING ALVEOLITIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC RISK; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MOTIF; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; GENE SILENCING; GENETICS; LUNG; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY;

BASE SEQUENCE; BINDING SITES; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA METHYLATION; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MUCIN-5B; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA POLYMERASE II; RNA, SMALL INTERFERING;

EID: 85021746464     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2017-0046OC     Document Type: Article

References (49)

1. Korfei M, Schmitt S, Ruppert C, Henneke I, Markart P, Loeh B, Mahavadi P, Wygrecka M, Klepetko W, Fink L, et al. Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. J Proteome Res 2011;10:2185-2205
2. Korfei M, Skwarna S, Henneke I, MacKenzie B, Klymenko O, Saito S, Ruppert C, von der Beck D, Mahavadi P, Klepetko W, et al. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis. Thorax 2015;70:1022-1032
3. Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, Crossman DK, Bray M, Zhang K, Thannickal VJ, Hagood JS. Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;186:525-535
4. Yang IV, Pedersen BS, Rabinovich E, Hennessy CE, Davidson EJ, Murphy E, Guardela BJ, Tedrow JR, Zhang Y, Singh MK, et al. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2014;190:1263-1272
5. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011;364:1503-1512
6. Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013;45:613-620
7. Zhang Y, Noth I, Garcia JG, Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med 2011;364: 1576-1577
8. Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP, Abraham DJ, Hansell DM, et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax 2013;68:436-441
9. Noth I, Zhang Y, Ma S-F, Flores C, Barber M, Huang Y, Broderick SM, Wade MS, Hysi P, Scuirba J, et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: α genomewide association study. Lancet Respir Med 2013;1:309-317
10. Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, Airo P, Matucci-Cerinic M, Wallaert B, Israel-Biet D, et al. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS One 2013;8:e70621
11. Coghlan MA, Shifren A, Huang HJ, Russell TD, Mitra RD, Zhang Q, Wegner DJ, Cole FS, Hamvas A. Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations. BMJ Open Respir Res 2014;1:e000057
12. Lee MG, Lee YH. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis. Inflamm Res 2015; 64:463-470
13. Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE, et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 2013;309: 2232-2239
14. Wang C, Zhuang Y, Guo W, Cao L, Zhang H, Xu L, Fan Y, Zhang D, Wang Y. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males. PLoS One 2014;9:e104919
15. Horimasu Y, Ohshimo S, Bonella F, Tanaka S, Ishikawa N, Hattori N, Kohno N, Guzman J, Costabel U. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis. Respirology 2015;20:439-444
16. Nakano Y, Yang IV, Walts AD, Watson AM, Helling BA, Fletcher AA, Lara AR, Schwarz MI, Evans CM, Schwartz DA. MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2016; 193:464-466
17. Pott S, Lieb JD. What are super-enhancers? Nat Genet 2015;47:8-12
18. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, et al. The accessible chromatin landscape of the human genome. Nature 2012;489:75-82
19. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009;459:108-112
20. Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, Kirkup VM, Wong MC, Maddren M, Fang R, Heitner SG, et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res 2013;41:D56-D63
21. Vincent A, Perrais M, Desseyn JL, Aubert JP, Pigny P, Van Seuningen I. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 2007;26:6566-6576
22. Saxonov S, Berg P, Brutlag DL. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci USA 2006;103: 1412-1417
23. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis: α population-based cohort study. Chest 1998; 113:396-400
24. Lyn-Cook L, Word B, George N, Lyn-Cook B, Hammons G. Effect of cigarette smoke condensate on gene promoter methylation in human lung cells. Tob Induc Dis 2014;12:15
25. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009; 5:e1000602
26. Tsou JA, Galler JS, Wali A, Ye W, Siegmund KD, Groshen S, Laird PW, Turla S, Koss MN, Pass HI, et al. DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer 2007; 58:220-230
27. Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA. The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 2009;4:e6767
28. Preciado D, Lin J, Wuertz B, Rose M. Cigarette smoke activates NFkB and induces Muc5b expression in mouse middle ear cells. Laryngoscope 2008;118:464-471
29. Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008;177:1338-1347
30. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al.; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188:733-748
31. Wu Q, Jiang D, Smith S, Thaikoottathil J, Martin RJ, Bowler RP, Chuw HW. IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M. J Allergy Clin Immunol 2012;129:825-833.e2
32. Berman R, Huang C, Jiang D, Finigan JH, Wu Q, Chu HW. MUC18 differentially regulates pro-inflammatory and anti-viral responses in human airway epithelial cells. J Clin Cell Immunol 2014;5:257
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDC(T) method. Methods 2001;25:402-408
34. Peljto AL, Selman M, KimDS, Murphy E, Tucker L, Pardo A, Lee JS, JiW, Schwarz MI, Yang IV, et al. The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in α Mexican cohort but is rare among Asian ancestries. Chest 2015;147:460-464
35. Meehan RR, Lewis JD, Bird AP. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 1992;20:5085-5092
36. Sarraf SA, Stancheva I. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell 2004;15:595-605
37. Savic D, Roberts BS, Carleton JB, Partridge EC, White MA, Cohen BA, Cooper GM, Gertz J, Myers RM. Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein b binding sites. Genome Res 2015;25:1791-1800
38. Gray TE, Guzman K, Davis CW, Abdullah LH, Nettesheim P. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol 1996;14: 104-112
39. Hao Y, Kuang Z, Jing J, Miao J, Mei LY, Lee RJ, Kim S, Choe S, Krause DC, Lau GW. Mycoplasma pneumoniae modulates STAT3-STAT6/EGFR-FOXA2 signaling to induce overexpression of airway mucins. Infect Immun 2014;82:5246-5255
40. Wang H, Maurano MT, Qu H, Varley KE, Gertz J, Pauli F, Lee K, Canfield T, Weaver M, Sandstrom R, et al. Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res 2012;22: 1680-1688
41. Pfaff SL. Developmental neuroscience: Hox and Fox. Nature 2008;455: 295-297
42. Brayer KJ, Lynch VJ, Wagner GP. Evolution of α derived protein-protein interaction between HoxA11 and Foxo1a in mammals caused by changes in intramolecular regulation. Proc Natl Acad Sci USA 2011; 108:E414-E420
43. Wan H, Kaestner KH, Ang SL, Ikegami M, Finkelman FD, Stahlman MT, Fulkerson PC, Rothenberg ME, Whitsett JA. Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 2004;131: 953-964
44. Sun L, Tang XJ, Luo FM. Forkhead box protein A2 and T helper type 2-mediated pulmonary inflammation. World J Methodol 2015;5: 223-229
45. Evans CM, Fingerlin TE, Schwarz MI, Lynch D, Kurche J, Warg L, Yang IV, Schwartz DA. Idiopathic pulmonary fibrosis: α genetic disease that involves mucociliary dysfunction of the peripheral airways. Physiol Rev 2016;96:1567-1591
46. Boucher RC. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 2007;58:157-170
47. Button B, Cai LH, Ehre C, Kesimer M, Hill DB, Sheehan JK, Boucher RC, Rubinstein M. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 2012;337: 937-941
48. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653
49. Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, et al. Muc5b is required for airway defence. Nature 2014;505: 412-416